Concepedia

Ikko Nakao

IN

Statistics

Publications

2

Citations

63

H-Index

2

Active since

2016

Affiliations

Nihon University(Current)

Astellas Pharma (Japan)

Ikko Nakao is an author at Nihon University specializing in diabetes management, clinical pharmacology, and diabetes pharmacotherapy.

Publications per year

2016–2018

2

Publications

2

Efficacy and safety of ipragliflozin as add‐on therapy to insulin in <scp>J</scp> apanese patients with type 2 diabetes mellitus ( <scp>IOLITE</scp> ): <scp>a</scp> multi‐centre, randomized, placebo‐controlled, double‐blind study

Hisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao et al. · Diabetes Obesity and Metabolism · 2016 · 49 citations · Full text

, , +17

Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study

Hisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao et al. · Diabetes Therapy · 2018 · 14 citations · Full text

, , +17

1–2 of 2